ES2945983T3 - Glucocorticoides muy potentes - Google Patents

Glucocorticoides muy potentes Download PDF

Info

Publication number
ES2945983T3
ES2945983T3 ES17860202T ES17860202T ES2945983T3 ES 2945983 T3 ES2945983 T3 ES 2945983T3 ES 17860202 T ES17860202 T ES 17860202T ES 17860202 T ES17860202 T ES 17860202T ES 2945983 T3 ES2945983 T3 ES 2945983T3
Authority
ES
Spain
Prior art keywords
alkyl
group
compound
dex
aliphatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES17860202T
Other languages
English (en)
Spanish (es)
Inventor
Huaqiang Xu
Yuanzheng He
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Van Andel Research Institute
Original Assignee
Van Andel Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Van Andel Research Institute filed Critical Van Andel Research Institute
Application granted granted Critical
Publication of ES2945983T3 publication Critical patent/ES2945983T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only
    • C07J71/0047Nitrogen only at position 2(3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES17860202T 2016-10-14 2017-10-13 Glucocorticoides muy potentes Active ES2945983T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662408314P 2016-10-14 2016-10-14
PCT/US2017/056447 WO2018071736A1 (en) 2016-10-14 2017-10-13 Structures and mechanism for the design of highly potent glucocorticoids

Publications (1)

Publication Number Publication Date
ES2945983T3 true ES2945983T3 (es) 2023-07-11

Family

ID=61906432

Family Applications (1)

Application Number Title Priority Date Filing Date
ES17860202T Active ES2945983T3 (es) 2016-10-14 2017-10-13 Glucocorticoides muy potentes

Country Status (12)

Country Link
US (1) US10954265B2 (enExample)
EP (1) EP3525870B1 (enExample)
JP (2) JP7146750B2 (enExample)
KR (1) KR102497070B1 (enExample)
CN (1) CN110382033B (enExample)
ES (1) ES2945983T3 (enExample)
MA (1) MA46539A (enExample)
PH (1) PH12019500801A1 (enExample)
RU (1) RU2019111101A (enExample)
SG (1) SG11201903209TA (enExample)
WO (1) WO2018071736A1 (enExample)
ZA (1) ZA201902595B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025119398A1 (zh) * 2023-12-08 2025-06-12 浙江柏拉阿图医药科技有限公司 高效力糖皮质激素多晶型及其制备方法和用途
WO2025157225A1 (zh) * 2024-01-24 2025-07-31 浙江柏拉阿图医药科技有限公司 一种高效力糖皮质激素化合物及其制备和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK66202C (da) 1945-03-03 1948-01-12 Danske Securitas As Kodekontakt til elektriske Alarmanlæg.
DK71662C (da) 1946-09-05 1950-11-06 Ingenioer Frank Broadbent Tørrecentrifuge.
US4049813A (en) 1976-07-15 1977-09-20 Sandoz, Inc. Substituted isoxazolo pyridinones
US5837698A (en) * 1996-05-02 1998-11-17 G. D. Searle & Co. Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
JPWO2002102807A1 (ja) 2001-06-14 2004-09-30 萬有製薬株式会社 新規イソキサゾロピリドン誘導体及びその用途
GB0119911D0 (en) 2001-08-15 2001-10-10 Novartis Ag Organic Compounds
CN1901863A (zh) * 2003-11-13 2007-01-24 康宾纳特克斯公司 治疗炎性疾病的方法和药物
CN101300265A (zh) * 2005-09-02 2008-11-05 尼科克斯公司 糖皮质激素硝酰氧基衍生物
CN1813768A (zh) * 2005-11-18 2006-08-09 成都力思特制药股份有限公司 治疗呼吸系统疾病的药用组合物及其在制药中的应用
EP2207788A1 (en) 2007-10-04 2010-07-21 AstraZeneca AB Steroidal [3, 2-c]pyrazole compounds, with glucocorticoid activity
CA2707618A1 (en) * 2007-12-20 2009-07-02 Astrazeneca Ab Steroid derivatives acting as glucocorticosteroid receptor agonists
WO2010083218A1 (en) 2009-01-13 2010-07-22 Van Andel Research Institute Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids
UY32520A (es) 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticoesteroides
UY32523A (es) 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
UY32525A (es) 2009-04-03 2010-10-29 Astrazeneca Ab Compuestos que tienen actividad agonista del receptor de glucocorticosteroides
EP2443134A2 (en) 2009-06-16 2012-04-25 Schering Corporation NOVEL [3,2-c]HETEROARYL STEROIDS AS GLUCOCORTICOID RECEPTOR AGONISTS, COMPOSITIONS AND USES THEREOF
AU2014324961A1 (en) * 2013-09-25 2016-04-14 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences Highly potent glucocorticoids
TWI695831B (zh) * 2014-09-13 2020-06-11 香港商南北兄弟藥業投資有限公司 Crth2拮抗劑化合物及其用途

Also Published As

Publication number Publication date
US10954265B2 (en) 2021-03-23
WO2018071736A9 (en) 2019-05-23
EP3525870A1 (en) 2019-08-21
JP2019532071A (ja) 2019-11-07
PH12019500801A1 (en) 2019-11-11
RU2019111101A (ru) 2020-11-16
EP3525870A4 (en) 2020-04-29
WO2018071736A1 (en) 2018-04-19
CN110382033B (zh) 2022-04-15
JP7146750B2 (ja) 2022-10-04
ZA201902595B (en) 2021-04-28
US20190263853A1 (en) 2019-08-29
EP3525870B1 (en) 2023-05-10
JP2022132464A (ja) 2022-09-08
KR20190068577A (ko) 2019-06-18
KR102497070B1 (ko) 2023-02-06
MA46539A (fr) 2019-08-21
SG11201903209TA (en) 2019-05-30
CN110382033A (zh) 2019-10-25
RU2019111101A3 (enExample) 2020-11-27

Similar Documents

Publication Publication Date Title
ES2751457T3 (es) Glucocorticoides altamente potentes
UA128369C2 (uk) Сполуки, що інгібують rip1, а також способи їх одержання та застосування
ES2658168T3 (es) Sales de tiazolidinadiona ahorradoras de PPAR para el tratamiento de enfermedades metabólicas
WO2019226991A1 (en) Androgen receptor modulators and methods for their use
KR20230008889A (ko) 아미노 피리미딘 ssao 억제제
JP6842474B2 (ja) ステロイド系化合物、当該化合物を含む組成物及びその使用
TW201619142A (zh) 利用替唑尼特(tizoxanide)、其類似物或鹽類之前驅藥的組成物及治療方法
CA2727890A1 (en) Compounds, compositions and treatments for v-atpase related diseases
EP3152209B1 (en) Naphthyridinedione derivatives as suppressors of non-sense mutations
TW202327620A (zh) 一種抗炎症的化合物及其用途
EP4483876A1 (en) Use of indazole compound for treating psoriasis
JP6313369B2 (ja) オーレオバシジン誘導体および合成方法
JP2022132464A (ja) 非常に強力な糖質コルチコイドの構造およびデザインのための機構
Zhang et al. Design, synthesis, and bioevaluation of novel NLRP3 inhibitor with IBD immunotherapy from the virtual screen
JP2014515741A5 (enExample)
TW201032810A (en) Treatment for glomerulonephritis
TWI746660B (zh) 尿素衍生物及其用途
HK40017057B (zh) 用於设计高效力糖皮质激素的结构与机制
HK40017057A (en) Structures and mechanism for the design of highly potent glucocorticoids
HK40070300A (en) Highly potent glucocorticoids
CN117940445A (zh) 大环免疫调节剂
HK40128804A (zh) 一种高效力糖皮质激素化合物及其制备和用途
WO2025157225A1 (zh) 一种高效力糖皮质激素化合物及其制备和用途
CN118159549A (zh) 免疫调节剂
TWI776810B (zh) 新穎二胺基吡啶衍生物